Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids - PubMed (original) (raw)
. 1999 Jun 3;18(22):3383-90.
doi: 10.1038/sj.onc.1202752.
Affiliations
- PMID: 10362359
- DOI: 10.1038/sj.onc.1202752
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids
K Perrem et al. Oncogene. 1999.
Abstract
Some immortalized cell lines maintain their telomeres in the absence of detectable telomerase activity by an alternative (ALT) mechanism. To study how telomere maintenance is controlled in ALT cells, we have fused an ALT cell line GM847 (SV40 immortalized human skin fibroblasts) with normal fibroblasts or with telomerase positive immortal human cell lines and have examined their proliferative potential and telomere dynamics. The telomeres in ALT cells are characteristically very heterogeneous in length, ranging from very short to very long. The ALT x normal hybrids underwent a rapid reduction in telomeric DNA and entered a senescence-like state. Immortal segregants rapidly reverted to the ALT telomere phenotype. Fusion of ALT cells to telomerase-positive immortal cells in the same immortalization complementation group resulted in hybrids that appeared immortal and also exhibited repression of the ALT telomere phenotype. In these hybrids, which were all telomerase-positive, we observed an initial rapid loss of most long telomeres, followed either by gradual loss of the remaining long telomeres at a rate similar to the rate of telomere shortening in normal telomerase-negative cells, or by maintenance of shortened telomeres. These data indicate the existence of a mechanism of rapid telomere deletion in human cells. They also demonstrate that normal cells and at least some telomerase-positive immortal cells contain repressors of the ALT telomere phenotype.
Similar articles
- Immortalized cells with no detectable telomerase activity. A review.
Reddel RR, Bryan TM, Murnane JP. Reddel RR, et al. Biochemistry (Mosc). 1997 Nov;62(11):1254-62. Biochemistry (Mosc). 1997. PMID: 9467849 Review. - A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT.
Cerone MA, Autexier C, Londoño-Vallejo JA, Bacchetti S. Cerone MA, et al. Oncogene. 2005 Nov 24;24(53):7893-901. doi: 10.1038/sj.onc.1208934. Oncogene. 2005. PMID: 16116482 - Telomerase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies.
Fasching CL, Bower K, Reddel RR. Fasching CL, et al. Cancer Res. 2005 Apr 1;65(7):2722-9. doi: 10.1158/0008-5472.CAN-04-2881. Cancer Res. 2005. PMID: 15805271 - Multiple pathways to cellular senescence: role of telomerase repressors.
Oshimura M, Barrett JC. Oshimura M, et al. Eur J Cancer. 1997 Apr;33(5):710-5. doi: 10.1016/S0959-8049(97)00090-7. Eur J Cancer. 1997. PMID: 9282109 Review. - Telomerase activation in human fibroblasts during escape from crisis.
Montalto MC, Phillips JS, Ray FA. Montalto MC, et al. J Cell Physiol. 1999 Jul;180(1):46-52. doi: 10.1002/(SICI)1097-4652(199907)180:1<46::AID-JCP5>3.0.CO;2-K. J Cell Physiol. 1999. PMID: 10362016
Cited by
- DNA C-circles are specific and quantifiable markers of alternative-lengthening-of-telomeres activity.
Henson JD, Cao Y, Huschtscha LI, Chang AC, Au AY, Pickett HA, Reddel RR. Henson JD, et al. Nat Biotechnol. 2009 Dec;27(12):1181-5. doi: 10.1038/nbt.1587. Nat Biotechnol. 2009. PMID: 19935656 - Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.
Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR. Perrem K, et al. Mol Cell Biol. 2001 Jun;21(12):3862-75. doi: 10.1128/MCB.21.12.3862-3875.2001. Mol Cell Biol. 2001. PMID: 11359895 Free PMC article. - Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy.
Gao J, Zhang W, Ehrhardt A. Gao J, et al. Cancers (Basel). 2020 May 2;12(5):1139. doi: 10.3390/cancers12051139. Cancers (Basel). 2020. PMID: 32370135 Free PMC article. Review. - PML body meets telomere: the beginning of an ALTernate ending?
Chung I, Osterwald S, Deeg KI, Rippe K. Chung I, et al. Nucleus. 2012 May-Jun;3(3):263-75. doi: 10.4161/nucl.20326. Epub 2012 May 1. Nucleus. 2012. PMID: 22572954 Free PMC article. Review. - Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression.
Chang S, Khoo CM, Naylor ML, Maser RS, DePinho RA. Chang S, et al. Genes Dev. 2003 Jan 1;17(1):88-100. doi: 10.1101/gad.1029903. Genes Dev. 2003. PMID: 12514102 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources